BHG Stock Price, News & Analysis

BHG historically represented Bright Health Group on public markets. Based on more recent disclosures, the business associated with this ticker has been reorganized and is now known as NeueHealth, Inc., which has operated under the NYSE symbol NEUE. According to multiple company news releases, NeueHealth describes itself as a value-driven healthcare company focused on coordinated care for health consumers, providers, and payors across major U.S. health coverage programs.

Company materials explain that NeueHealth is grounded in the belief that all health consumers are entitled to high-quality, coordinated care. Its stated approach is to align the interests of health consumers, providers, and payors to help make healthcare more accessible and affordable across the ACA Marketplace, Medicare, and Medicaid. The company reports that it delivers clinical care through owned clinics and through partnerships with affiliated providers, and that it supports independent providers and medical groups in performance-based arrangements using a centrally scaled, locally deployed suite of technology and services.

In several earnings and transaction announcements, NeueHealth emphasizes a value-driven, consumer-centric care model. The company states that this model is intended to create a more seamless and coordinated care experience by connecting clinical, financial, and administrative functions. It highlights the role of its enablement platform in supporting performance-based arrangements and in helping providers participate in value-based care programs.

Corporate communications also reference business activity across distinct product or program categories, including the ACA Marketplace, Medicare, Medicaid, and ACO REACH arrangements. The company has discussed value-based consumers served, enablement services lives, and performance under these arrangements as key metrics in its financial updates.

In an October 2024 announcement, NeueHealth reported that one of its value-driven clinic brands, Centrum Health, became a wholly owned subsidiary through the acquisition of the remaining equity interest it did not already own. The company stated that this step was intended to simplify its corporate structure and support its focus on advancing its value-driven, consumer-centric care model.

On December 23, 2024, NeueHealth announced that it had entered into an Agreement and Plan of Merger with NH Holdings 2025, Inc., an entity indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. (NEA). Under that agreement, NeueHealth would become a wholly owned subsidiary of NH Holdings 2025, Inc., subject to regulatory and stockholder approvals and other customary conditions. The company indicated that, following completion of the transaction, its common stock would no longer be publicly traded.

On October 2, 2025, NeueHealth announced the successful closing of this take-private transaction. In that release, the company stated that it had been acquired by an affiliate of NEA and that its common stock had ceased trading on the New York Stock Exchange on October 2, 2025. NeueHealth also indicated that it intended to make the applicable filings with the U.S. Securities and Exchange Commission to suspend its periodic reporting obligations and to terminate the registration of the Class A shares underlying its active registration statements.

For users researching the historical BHG stock, it is important to recognize that the public company associated with this ticker has undergone significant restructuring and a name and symbol transition, and has ultimately been taken private. Historical descriptions of Bright Health’s activities as a health insurance-focused business should be understood in the context of this later evolution into NeueHealth and the subsequent acquisition by an NEA affiliate.

Business focus and care model

Across multiple news releases, NeueHealth consistently describes its role as a value-driven healthcare company that delivers high-quality clinical care to health consumers and supports independent providers. It reports serving hundreds of thousands of health consumers through a combination of owned clinics and partnerships with more than 3,000 affiliated providers. The company also states that it enables independent providers and medical groups to participate in performance-based arrangements through technology and services that are scaled centrally and deployed locally.

The company’s communications emphasize that its care model is designed to align incentives among consumers, providers, and payors, with the goal of improving coordination of care and making healthcare more accessible and affordable. It highlights activity across ACA Marketplace, Medicare, and Medicaid programs, as well as ACO REACH arrangements, as key areas where this model is applied.

Corporate transformation and trading status

From the perspective of the BHG ticker, the most significant developments are the corporate transformation and change in trading status described in NeueHealth’s announcements. On December 23, 2024, NeueHealth disclosed that it had entered into a definitive merger agreement under which it would be acquired by an affiliate of NEA at an enterprise value of approximately $1.3 billion, with the expectation that its common stock would cease to be publicly traded upon completion of the transaction.

On October 2, 2025, NeueHealth reported that this take-private transaction had closed at an enterprise value of approximately $1.465 billion, and that its common stock had ceased trading on the New York Stock Exchange on that date. The company further stated that it intended to suspend its periodic reporting obligations and terminate the registration of its Class A shares. These disclosures indicate that the public listing associated with NeueHealth, and by extension the historical BHG context, has transitioned into a privately held structure.

Use of this page

This overview should be read as a historical and structural summary for investors and researchers examining the legacy BHG symbol and the evolution of the underlying business into NeueHealth and its subsequent acquisition by an NEA affiliate. For detailed, time-specific financial information or regulatory disclosures, users should consult the company’s historical filings and official communications for the relevant periods.